Ostarine (MK2866) is classified as a SARM. It was initially developed to treat and prevent muscle wastage amongst cancer and osteoporosis patients. It has been considered and hoped to be used for preventing muscle atrophy, cachexia and sarcopnia and has also been discussed for use during TRT/HRT.
MK2866 almost exclusively exerts its anabolic effects on muscle tissue and minimizes muscle atrophy, most notably during recovery periods from surgeries and injuries. This makes MK useful and desirable in numerous instances. MK is highly effects at gaining and/or maintaining extremely lean body mass.
50MG X 30/ML